Asian Spectator

Men's Weekly

.

Publication of First In-Human Data Reveals Safety Efficacy o...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
BRISBANE, Australia, Dec. 9, 2019 /PRNewswire-AsiaNet/ -- - First in-human Clinical Phase I study of intratumoural tigilanol tiglate (EBC-46) has been published in The Lancet's EBioMedicine journal; - An efficacious dose was achieved and a Maximum Tolerated Dose (MTD) was not reached, indicating tigila...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

Diplomasi mendadak Prabowo jadi mediator AS - Iran: Langkah berani atau cari panggung?

(DPN)● Rencana Prabowo mediasi Amerika-Iran memicu keraguan.● Prabowo seakan ingin berperan seimbang untuk bertahan dari tekanan dari luar dan dalam negeri .● Tanpa daya tawar, media...

Masa depan padel: Antara gengsi atau turun kelas agar tren ini langgeng

● Padel sedang menjadi tren teratas aktivitas kaum urban sejak beberapa tahun terakhir.● Padel sudah menjelma sebagai validasi gaya hidup modern pemainnya.● Tren main padel akan sege...

The world’s largest climate finance deal was built to flounder: why funding fails to reach the front-line

Adopted in December 2015, the Paris Agreement commits countries to keeping global temperature rise below 2°C above pre-industrial levels. All 195 signatories set their own plans to meet this share...